Department of Urology
Fudan University Shanghai Cancer Center, Shanghai
泌尿外科 · Urology
Established in 2002, this department focuses on the diagnosis, treatment, and research of urological and male reproductive system tumors. It operates with a multidisciplinary team (MDT) approach, combining standardized surgery with radiotherapy, chemotherapy, endocrine therapy, interventional therapy, targeted therapy, and immunotherapy. The department manages specialized units for prostate, bladder, kidney, and penile/testicular tumors. It also conducts clinical trials for new drugs and devices. According to hospital statistics from 2019, the team performed over 4,200 inpatient surgeries, primarily radical procedures for malignant tumors, and nearly 12,000 outpatient procedures.
What the department treats
- Surgical treatment for prostate, bladder, kidney, and penile/testicular tumors
- Multidisciplinary team (MDT) consultations for complex cases
- Radiotherapy, chemotherapy, and immunotherapy for urological cancers
- Prostate biopsy and bladder cystoscopy
- Participation in clinical trials for new urological drugs and devices
- Outpatient surgical procedures and tumor management
Key facts
- The department was founded in 2002 and currently has 130 inpatient beds.
- In 2019, the team performed 4,286 inpatient surgeries and nearly 12,000 outpatient procedures.
- The department's biobank holds over 14,000 paired blood, urine, and tissue samples from patients.
As described by the hospital.
Team
30 doctors listed, including 3 chief physicians. Its chief physicians have 21 first- or senior-author papers on PubMed since 2016.
| Chief physician | Clinical focus | Key papers since 2016 |
|---|---|---|
| Dr. Yiping Zhu 朱一平 · Associate Professor | Diagnosis and treatment of urinary system tumors, with a focus on bladder cancer. Expertise includes early diagnosis, minimally invasive surgery, robotic and laparoscopic radical cystectomy with orthotopic neobladder, bladder-preserving therapy for invasive cancer, and comprehensive care for advanced bladder cancer, renal pelvis cancer, and ureteral cancer. | 14 |
| Dr. Xiaojian Qin 秦晓健 | Surgical treatment of advanced and complex prostate cancer, minimally invasive nerve-sparing radical prostatectomy for early-stage disease, comprehensive management of advanced prostate cancer, benign prostatic hyperplasia, differential diagnosis of prostatitis and prostate cancer, and multidisciplinary care for urologic tumors. | 4 |
| Dr. Guohai Shi 施国海 · Associate Professor | Diagnosis, surgery, and minimally invasive treatment of urinary tract tumors; systemic therapy for advanced tumors including molecular targeted therapy; diagnosis and treatment of tuberous sclerosis. | 3 |
Associate chief physicians
- Dr. Guowen Lin林国文
- Dr. Wenjun Xiao肖文军
- Dr. Dalong Cao曹达龙
- Dr. Yu Zhu朱煜
- Dr. Hengchuan Su宿恒川
- Dr. Chengyuan Gu顾成元
- Dr. Chunguang Ma马春光
- Dr. Yuanyuan Qu瞿元元
- Dr. Hongkai Wang王弘恺
- Dr. Hua Xu许华
- Dr. Fangning Wan万方宁
- Dr. Xiaojie Bian卞晓洁
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion